Bioxodes
Phase 2Bioxodes is a clinical stage biopharmaceutical company developing a first-in-class drug candidate, Ir-CPI, for the prevention of thrombosis and neuroinflammation in hemorrhagic stroke patients.
Founded
2013
Focus
Biologics
About
Bioxodes is a clinical stage biopharmaceutical company developing a first-in-class drug candidate, Ir-CPI, for the prevention of thrombosis and neuroinflammation in hemorrhagic stroke patients.
Company Info
TypePrivate
Founded2013
LocationGosselies, Belgium
StagePhase 2
Contact
SIMILAR COMPANIES
Miracor Medical
Pre-clinical · Zaventem
AML Clinical Services
Pre-clinical · Leuven
Anacura
Pre-clinical · Ghent
Aseptic Technologies
Pre-clinical · Gembloux
Aspect Analytics
Pre-clinical · Leuven
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile